Buehlmann


anti-GM1

...The expert's choice – your assay For motor neuropathies

test

Anti-GM1 antibodies:

Microtiter Plates of the anti-GM1-GM ELISA Kit are uniformly coated with GM1 antigen. There are many different options for using the plate and two are shown in Figures below:

 

 

Fig 1a

Indications for use of anti-GM1 ELISA
Antibodies to ganglioside M1 (GM1, anti-GM1). IgG antibodies) are implicated in the pathogenesis of Guillain-Barré Syndrome (GBS) and anti-GM1 IgM antibodies in multifocal neuropathy (MMN) and motor neuron disease (MND).
GM1 IgM antibodies may be present as monoclonal IgM paraprotein or as a polyclonal IgM. Polyclonal IgG may be detected in patients with motor neuropathies. High GM1 antibody titers may be detected in association with in Guillain-Barré Syndrome (GBS) following Campylobacter jejuni infection.
The fact that GM1 is the only common Glycolipid antigen reactive with all of the GM1 antibodies found in motor nerve disorders suggests that it is the relevant target antigen in neural tissue.

Product Information

anti-Gm1 anti-GM1-GM

Method

ELISA ELISA

Time to results

4.5 h 4.5 h

Sample Type

20 µl serum (1:50) 20 µl serum (1:50)

Standard range

800-15000 BTU quantitative new standardisation

Isotypes

IgG and IgM IgG and gM

Order code

EK-GM1 96 wells EK-GM1-GM 96 wells
CE CE

DOWNLOADS

Instruction
for use* for anti-GM1-GM

Clinical Information

Technical Information

English


[PDF 0.3MB]
[PDF 0.4MB] [PDF 0.3MB]

Deutsch

[PDF 0.3MB]

Français

- [PDF 0.3MB]

Italiano

- -

* Multilingual document [EN, DE, FR, IT, ES]

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2  more

Measuring of Mineralwaters and Softdrinks on Arena and Aquakem

The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe  more

BÜHLMANN Calprotectin Test introduced in Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro  more

Distribution of BioPorto’s NGAL ELISA

In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France .  more

Get our RSS - Feed